Policy paper

Cannabis-based medicines expert panel: terms of reference

This terms of reference sets out the scope of the expert panel, who assess applications for special licences to prescribe cannabis-based medicinal products.

From:
Home Office
Published
27 June 2018
Last updated
10 July 2018 — See all updates
This was published under the 2016 to 2019 May Conservative government

This publication was withdrawn on

Cannabis-based medicines expert panel no longer exists.

Documents

Cannabis-based medicinal products panel: terms of reference

PDF, 269 KB, 3 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The terms of reference sets out the factors the expert panel will take into account to assess applications for special licences to prescribe cannabis-based medicinal products, to inform recommendations to the Home Secretary and the Department of Health in Northern Ireland.

Updates to this page

Published 27 June 2018
Last updated 10 July 2018 + show all updates

  1. Updated terms of reference.

  2. First published.

Sign up for emails or print this page